Titan Pharmaceuticals Regains Compliance with Nasdaq Listing

Titan Pharmaceuticals (TTNP) has released an update.

Titan Pharmaceuticals, Inc. has been informed that it now complies with the Nasdaq’s minimum bid price requirement and meets all other criteria for continued listing on The Nasdaq Capital Market, resolving the previous listing issue.

For further insights into TTNP stock, check out TipRanks’ Stock Analysis page.